ArticleCureus2025
Complex Venous Thromboembolism in a Young Woman With Multisystem Manifestations: A Case Report.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Venous thromboembolism (VTE) in adolescents is rare and often necessitates a comprehensive evaluation for both inherited and acquired prothrombotic conditions. We report the case of an 18-year-old female who initially presented with cerebral venous sinus thrombosis (CVST). Anticoagulation with warfarin was complicated by massive gastrointestinal bleeding, followed by deep vein thrombosis (DVT) and recurrent thrombotic events, including superior mesenteric venous thrombosis with bowel infarction. Laboratory investigations revealed sickle cell trait (HbS 38.3%), heterozygous mutations in lymphotoxin alpha (LTA C804A), Factor V R2 (H1299R), and methylenetetrahydrofolate reductase (MTHFR C677T), with normal homocysteine levels. The autoimmune panel was negative apart from borderline high cardiolipin immunoglobulin G (IgG). Owing to recurrent bleeding, anticoagulation proved challenging, and she was ultimately managed with apixaban and clopidogrel. This case illustrates the synergistic impact of multiple mild thrombophilic factors and sickle cell trait, underscores the need to consider mesenteric venous thrombosis in abdominal emergencies, and highlights the clinical challenge of balancing thrombosis prevention with bleeding risk.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.